Karmous Inchirah, Sayed Khan Amira, Sahnoun Imen, Ben Othman Rym, Ben Jemaa Houda, Mahjoub Faten, Gamoudi Amel, Douik El Gharbi Leila, Mestiri Tahar, Khan Naim Akhtar, Jamoussi Henda
Research Unit on Obesity UR18ES01, Faculty of Medicine, University Tunis El Manar, 15 Rue Jebel Lakhdar, Beb Saadoun, Tunis 1007, Tunisia.
Centre de Recherche Inserm, U1231 INSERM/UB/Institut Agro, Team-Physiologie de la Nutrition & Toxicologie, Faculté des Sciences de la Vie, Université de Bourgogne Franche-Comté (UBFC), 21000 Dijon, France.
J Clin Med. 2023 Jan 11;12(2):597. doi: 10.3390/jcm12020597.
Taste disorders (TDs) have been reported to be very common in patients suffering from coronavirus disease 2019 (COVID-19), which is caused by the SARS-CoV-2 virus. In most of the hitherto conducted studies, a gustatory assessment was performed on the basis of surveys or self-reports by patients. The aim of our study was to undertake an objective assessment of four basic taste qualities by conducting tasting sessions that allowed detection thresholds in COVID-19 Tunisian patients and to study their associations with inflammation.
This analytical cross-sectional study was conducted on 89 patients aged between 21 to 70 years who had been diagnosed with COVID-19. We used Burghart taste strips to assess taste perception of the four taste qualities, i.e., sour, bitter, sweet, and salty. Serum levels of interleukin-1β (IL-1β), interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α), and C-reactive protein (CRP) were measured.
Taste disorders were reported by 40.4% of the patients, while objective assessments revealed that 63.8% of participants were suffering from hypogeusia and/or ageusia. Sour taste was the most altered (70.8%) gustatory quality. Patients with severe COVID-19 had significantly lower sour and bitter taste scores when compared to patients with minor/moderate forms. There was no significant association between serum inflammatory markers and taste disorders. However, the relationship between bitter and sweet taste qualities and IL-1β levels was significant ( = 0.018 and = 0.041).
Our results demonstrate the interest in the objective assessment of taste dysfunctions in COVID-19 patients.
据报道,味觉障碍(TDs)在感染2019冠状病毒病(COVID-19,由严重急性呼吸综合征冠状病毒2型即SARS-CoV-2病毒引起)的患者中非常常见。在迄今为止进行的大多数研究中,味觉评估是基于患者的调查或自我报告进行的。我们研究的目的是通过进行味觉测试来对四种基本味觉特性进行客观评估,从而检测突尼斯COVID-19患者的味觉阈值,并研究它们与炎症的关联。
这项分析性横断面研究对89名年龄在21至70岁之间、已被诊断为COVID-19的患者进行。我们使用Burghart味觉试纸评估四种味觉特性(即酸、苦、甜和咸)的味觉感知。测量血清白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)和C反应蛋白(CRP)水平。
40.4%的患者报告有味觉障碍,而客观评估显示63.8%的参与者存在味觉减退和/或味觉丧失。酸味是受影响最大(70.8%)的味觉特性。与轻症/中症患者相比,重症COVID-19患者的酸味和苦味得分显著更低。血清炎症标志物与味觉障碍之间无显著关联。然而,苦味和甜味特性与IL-1β水平之间的关系显著(P = 0.018和P = 0.041)。
我们的结果表明对COVID-19患者味觉功能障碍进行客观评估具有重要意义。